AB308

Overview

AB308 is an anti-TIGIT antibody that is FcR-enabled.

SparkCures ID 411
Developed By Arcus Biosciences, Inc.
Generic Name AB308

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.